Skip to main content
 

Biosimilars Forum Statement on the Introduction of Biosimilars in the United States

WASHINGTON, DC, (September 3, 2015) – “The Biosimilars Forum commends the introduction today of biosimilars in the United States. Today’s launch of the first US biosimilar is evidence that the US pathway for biosimilars is viable. Members of the Forum look forward to bringing many other biosimilars to the market. There are still a few regulatory and reimbursement issues that need to be resolved. We look forward to working with FDA, CMS, and others to resolve these issues. Our mission will be to continue to educate health care professionals and patients about the value that biosimilars will provide. We believe thousands of patients with serious diseases will benefit from increased access to treatment options once they are launched.”


About the Biosimilars Forum:

The Biosimilars Forum will advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The Biosimilars Forum will provide evidence-based information to inform and support public policies that encourage access, awareness and adoption of biosimilars.

To learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org or go to @USBiosimilars to follow related conversations and join the dialogue.

Contact:
Aimee Steel
202.828.1895
aimee.steel@hklaw.com

Media:
Lynn Blenkhorn
617.761.6766
biosimilars@fkhealth.com

Date

Thursday, September 3, 2015